GlutathioneCosmetic / Skin

Overview

Glutathione (GSH) is a thiol tripeptide, gamma-L-glutamyl-L-cysteinylglycine, synthesized in essentially every human cell and present at millimolar concentrations — the body's principal intracellular antioxidant. It cycles between reduced (GSH) and oxidized (GSSG) forms to buffer cellular redox state. It is a normal dietary metabolite and a non-prescription supplement, not an FDA-approved drug; it is also used off-label as a compounded IV "wellness"/skin-lightening agent. Note its unusual gamma-glutamyl bond, which makes it a metabolite rather than a ribosomally translated peptide.

Mechanism

GSH is the electron-donating cofactor for glutathione peroxidases (reducing peroxides to water while being oxidized to GSSG) and glutathione-S-transferases (conjugating GSH onto electrophiles for hepatic phase-II detoxification). GSSG is recycled to GSH by NADPH-dependent glutathione reductase. GSH also regenerates vitamins C and E and modulates protein thiols by S-glutathionylation. Human RCT data show oral supplementation can raise tissue GSH stores, though the oral bioavailability of intact GSH remains scientifically debated.

Clinical evidence

Human evidence is moderate and mixed. A 6-month double-blind RCT (Richie 2015) found oral GSH raised glutathione stores and NK-cell activity. For Parkinson's disease, an intranasal phase I/IIa trial (Mischley 2015) established tolerability, but the larger phase IIb RCT (Mischley 2017) found GSH was not superior to placebo — the placebo arm improved similarly. For cosmetic skin-lightening, a 2025 narrative review notes no controlled trials support injectable GSH for whitening and documents serious harms. Animal/in-vitro data support antioxidant and hepatoprotective roles not yet confirmed by robust human outcome trials.

Safety profile

In controlled trials, oral and intranasal glutathione were well tolerated (mild GI upset, flushing). The major concern is parenteral cosmetic use: regulators (including the Philippine and US FDA) have warned against IV glutathione for skin lightening, and dermatology reviews document anaphylaxis, hepatotoxicity, renal/thyroid dysfunction, Stevens-Johnson syndrome, and endotoxin contamination of non-sterile compounded injectables — risks driven by the unregulated IV route, not the molecule. It is not WADA-prohibited, though a high-volume IV infusion is itself a banned method. Not an FDA-approved drug; research/supplement framing only.

Compare

• vs NAD+

  Both are endogenous non-peptide metabolites marketed for IV wellness; glutathione is the body's principal thiol antioxidant for redox detox, while NAD+ is a redox coenzyme central to energy metabolism.

• vs Methylene Blue

  Both touch cellular redox biology, but methylene blue is an FDA-approved redox-cycling drug with serious interactions, whereas glutathione is an antioxidant supplement whose main risks come from the unregulated IV cosmetic route.